This brand name is authorized in Japan
The drug QUENMET contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Potassium citrate
UNII EE90ONI6FF - POTASSIUM CITRATE
|
|
Citrate and citric acid solutions are systematic and urinary alkalinizers thereby providing symptomatic relief of dysuria. |
|
2
Sodium citrate
UNII B22547B95K - TRISODIUM CITRATE DIHYDRATE
|
|
Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3949101A1190, 3949101F1120 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
